Rare
lephants
Screener
Toggle theme
TransMedics Group, Inc.
TMDX
·
Healthcare, Medical Devices, United States
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Cash Flow History
Net Cash Flow Breakdown
Net Cash Flow
Cash Flow
›
Net Cash Flow Breakdown
Net Cash Flow Breakdown
Chart
Table
FY2025
FY2024
Total Cash from Operations:
$272.5M
Line Item
Value
% of Total
Capital Expenditures
$59.3M
21.7%
Working Capital
$61.5M
22.6%
Net Cash Flow
$151.7M
55.7%
Download CSV
